juglone has been researched along with Alloxan Diabetes in 2 studies
juglone: structure
juglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costantino, S | 1 |
| Paneni, F | 1 |
| Lüscher, TF | 1 |
| Cosentino, F | 1 |
| Liu, X | 1 |
| Liang, E | 1 |
| Song, X | 1 |
| Du, Z | 1 |
| Zhang, Y | 1 |
| Zhao, Y | 1 |
2 other studies available for juglone and Alloxan Diabetes
| Article | Year |
|---|---|
Pin1 inhibitor Juglone prevents diabetic vascular dysfunction.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA; Endothelium, | 2016 |
Inhibition of Pin1 alleviates myocardial fibrosis and dysfunction in STZ-induced diabetic mice.
Topics: Actins; Animals; Animals, Newborn; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cult | 2016 |